Antibacterials for the prophylaxis and treatment of bacterial endocarditis in children

Paediatric Drugs

Volumn 3, Issue 10, 2001, Pages 703-718

  Capitano, B ^a   Quintiliani, R ^a   Nightingale, C H ^a   Nicolau, D P ^a  

^a HARTFORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEFADROXIL; CEFALEXIN; CEFAZOLIN; CEFTRIAXONE; CLARITHROMYCIN; CLINDAMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; DICLOXACILLIN; GENTAMICIN; GLYCOPEPTIDE; LINEZOLID; MACROLIDE; NAFCILLIN; OXACILLIN; PENICILLIN DERIVATIVE; PENICILLIN G; RIFAMPICIN; VANCOMYCIN;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; BACTERIAL ENDOCARDITIS; CHILD; DOSE RESPONSE; ENTEROCOCCUS; HAEMOPHILUS PARAINFLUENZAE; HIGH RISK POPULATION; HUMAN; INFECTION PREVENTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PENICILLIN ALLERGY; PHARMACODYNAMICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; STREPTOCOCCUS BOVIS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

EID: 0034760710     PISSN: 11745878     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128072-200103100-00001     Document Type: Review

References (68)

1. A forty-year review of bacterial endocarditis in infancy and childhood
2. Infective endocarditis: 35 years of experience at children's hospital
3. Infective endocarditis in children with congenital heart disease: The changing spectrum
4. The changing pattern of infective endocarditis in childhood
5. Pediatric infective endocarditis in the modern era
6. Infective endocarditis in infants and children during the past 10 years: A decade of change
7. Trends of childhood infective endocarditis in Israel with emphasis on children under 2 years of age
8. Pediatric bacterial endocarditis: Treatment and prophylaxis
9. Infective endocarditis in children: Clinical analyses and evaluation of two diagnostic criteria
10. Infective endocarditis in infants and children
11. Infective endocarditis
12. Infective endocarditis
13. Infective endocarditis
14. Pharmacokinetic and pharmacodynamic considerations in antibiotic selection with particular attention to oral cepahlosporins
15. Endocarditis and intravascular infections
16. Antimicrobial treatment of infective endocarditis due to viridans streptococci, enterococci and staphylococci
17. Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci and HACEK microorganisms
18. Serum bactericidal activity as a monitor of antibiotic therapy
19. Effect of antibiotic treatment on vegetation size and complication rate in infective endocarditis
20. Rate of methicillin penetration into normal heart valves and experimental endocarditis lesions
21. Antibiotic penetration of and bactericidal activity within endothelial cells
22. Pharmacokinetic and pharmacodynamic requirements for antibiotic therapy of experimental endocarditis
23. Medical treatment of infective endocarditis: General principles
24. Endocarditis due to group A beta-hemolytic streptococcus in children with potentially lethal sequelae: 2 cases and review
25. Multicenter collaborative evaluation of a standardized serum bactericidal test as a prognostic indicator in infective endocarditis
26. Discrepancies between MBC and actual killing of viridans group streptococci by cell-wall-active antibiotics
27. The serum bactericidal test
28. Integration of pharmacokinetics and pharmacodynamics of methicillin in curative treatment of experimental endocarditis
29. The pharmacodynamics of β-lactams
30. Evaluation of antibiotic diffusion into cardiac vegetations by quantitative autoradiography
31. The pharmacodynamics of aminoglycosides
32. Pharmacokinetic and pharmacodynamic aspects of therapy experimental endocarditis
33. In vivo antibiotic synergism: Contribution of animal models
34. Comparison of penicillin and vancomycin, individually and in combination with gentamicin and amikacin, in the treatment of experimental endocarditis induced by nutritionally variant streptococci
35. Carriage of multidrug resistant streptococcus pneumoniae and impact of chemoprophylaxis during an outbreak of meningitis at a day care center
36. Endocarditis caused by drug-resistant streptococcus pneumoniae in a child
37. Pneumococcal endocarditis in infants and children: Report of a case and review of the literature
38. Antibiotic treatment of streptococcal, enterococcal and staphylococcal endocarditis
39. Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant staphylococcus aureus endocarditis
40. Influence of resistance to streptogramin A type antibiotics on the activity of quinupristindalfopristin in vitro and in experimental endocarditis due to staphylococcus aureus
41. Quinupristin/dalfopristin: A review of its use in the management of serious gram-positive infections
42. Critical influence of resistance to streptogramin b-type antibiotics on activity of rp 59500 in experimental endocarditis due to staphylococcus aureus
43. Experience with quinupristin/dalfopristin in treating infections with vancomycin resistant Enterococcus faecium in children
44. Prevention of bacterial endocarditis: Recommendations by the American Heart Association
45. Antibiotic prophylaxis for medical and dental procedures
46. Prevention of bacterial endocarditis
47. Infective endocarditis prophylaxis in children
48. Bacteremia in children following dental extraction
49. Prevention of bacterial endocarditis: Recommendations by the American Heart Association
50. ACC/AHA guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Valvular Heart Disease)
51. Efficacy of azithromycin or clarithromycin for prophylaxis of viridans group streptococcus experimental endocarditis
52. Single oral-dose azithromycin prophylaxis against experimental streptococcal or staphylococcal aortic valve endocarditis
53. Dental therapeutic indications for the newer long-acting macrolide antibiotics
54. 'Dentists are innocent!' Everyday bacteremia is the real culprit: A review and assessment of the evidence that dental surgical procedures are a principal cause of bacterial endocarditis in children
55. Incidence of postextraction bacteremia under penicillin cover in children with cardiac disease
56. Bacterial endocarditis prophylaxis: What is recommended and what is practiced?
57. Dental and cardiac risk factors for infective endocarditis
58. Does prophylaxis prevent postdental infective endocarditis: A controlled evaluation of protective efficacy
59. Dental bacteremia in children
60. Physician and dentist compliance with American Heart Association guidelines for prevention of bacterial endocarditis
61. Apparent failures of endocarditis prophylaxis: Analysis of 52 cases submitted to a national registry
62. Penicillin prophylaxis in children with cardiac disease: Postextraction bacteremia and penicillin-resistant strains of viridans streptococci
63. Infective endocarditis in children following dental extraction and appropriate antibiotic prophylaxis
64. Resistance in oral streptococci after repetition of a single-dose amoxicillin prophylactic regimen
65. Emergence of antibiotic resistant streptococcus sanguis in dental plaque of children after frequent antibiotic therapy